johnk@mrsc.ucsf.edu
(415) 353-9410 (voice)
(415) 353-9423 (fax)

Box 0946; San Francisco, CA 94143-0946

New College, Sarasota, FL, B.S., 1976-1982, Chemistry
University of South Florida, Tampa, FL, Ph.D., 1982-1987, Chemistry
University of California San Francisco, CA, Post-Doc., 1987-1990, In vivo Spectroscopy

(34 out of 87)

Kurhanewicz J, Thomas A, Jajodia P, Weiner M, James TL, Vigneron DB, Narayan P. P-31 Spectroscopy of the Human Prostate Gland In Vivo using a Transrectal Probe. Magn Res Med. 1991;22(2):403-413.

Kurhanewicz J, Vigneron DB, Nelson SJ, Hricak H, Macdonald JM, Badrinath K, Narayan P. Citrate as a In Vivo Marker to Discriminate Prostatic Cancer from Benign Prostatic Hyperplasia and Normal Peripheral Zone: Detection via Localized Proton Spectroscopy. Urology 1995;45(3):1-9.

Kurhanewicz J, Vigneron D, Hricak H, Carroll P, Narayan P, Nelson S. Three-Dimensional H-1 MR Spectroscopic Imaging of the In Situ Human Prostate with High (0.24-0.1-CM(3)) Spatial Resolution. Radiology 1996;198:795-805.

Kurhanewicz J, Hricak H, Vigneron DB, Nelson S, Parivar F,Shinohara K, Carroll PR. Prostate Cancer: Metabolic Response to Cryosurgery as Detected with 3D H-1 MR Spectroscopic Imaging. Radiology 1996;200:489-496.

Scheidler J, Hricak H, Vigneron D, Yu K, Sokolov DL, Huang LR, Nelson S, Zaloudek CJ, Carroll PR, Kurhanewicz J. Combined Utility (Use) of H-1 Spectroscopic Imaging in Localizing Prostate Cancer: Clinico-Pathologic Study. Radiology 1999; 213:473-480.

Yu KK, Scheidler J, Hricak H, Vigneron DB, Zaloudek C, Nelson S,Carroll P, Kurhanewicz J. Improved Prediction of Extracapsular Extension in Patients with Prostate Cancer by the Addition of 3D 1H-MR Spectroscopic Imaging to MR Imaging. Radiology 1999;213:481-488.

Wefer AE, Hricak H, Vigneron DB, Coakley FV, Lu.Y, Wefer J, Muller-Lisse U, Carroll PR, Kurhanewicz J. Sextant localization of prostate cancer: Comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step-section histology. Journal of Urology 2000;164(2)400-404.

Kurhanewicz J, Swanson MG, Wood PJ, Vigneron DB. Magnetic Resonance Imaging and Spectroscopic Imaging: Improved Patient Selection and Potential for Metabolic Intermediate Endpoints in Prostate Cancer Chemoprevention Trials. Urology 2001;57(Supplemet 4A)124-128.

Swanson MG, Vigneron DB, Hurd RE, Sailasuta N, Tran T-K, Kurhanewicz J. Single Voxel Oversampled 2D J-Resolved Spectroscopy of In Vivo Human Prostate Tissue. Magnetic Resonancne In Medicine 2001;45:973-980.

Mueller-Lisse UG, Swanson M, Vigneron DB, Hricak H, Males R, Wood P, Noworolski S, Nelson SJ, Barken I, Carroll PR, Kurhanewicz J. Hormone Ablation of Localized Prostate Cancer: Time-Dependent Therapy Effects on Prostate Metabolism Detected by 3D 1H MR Spectroscopy. Magnetic Resonance In Medicine 2001;46:49-57.

Coakley FV, Hricak H, Wefer AE, Speight JL, Kurhanewicz J, Roach M. Endorectal MR imaging of treatment-related changes after brachytherapy for prostate cancer. Radiology 2001;219(3):817-821.

Mueller-Lisse UG, Vigneron DB, Hricak H, Swanson MG, Carroll P, Bessette A, Scheidler J, Srivastava A, Males RM, Cha I, Kurhanewicz J. Localized Prostate Cancr: Effect of Hormone Deprivation Therapy Meayred by Combined Three-dimensional 1H-MR Spectroscopy and MR Imaging: Clinico-Pathologic Case-Control Study. Radiology 2001;221:380-390.

Roach M, Kurhanewicz J, Carroll PR. Spectroscopy in Prostate Cancer: Hope or Hype? Oncology 2001; 15(11)1399-1410 (Editorials on 1415-1418).

Coakley FV, Kurhanewicz J, Lu Y, Jones KD, Swanson MG, Chang SD, Carroll PR, Hricak H. Prostate cancer tumor volume: Measurement with endorectal MR and MR Spectroscopic Imaging. Radiology 2002;223: 91-97.

Kurhanewicz J, Swanson M, Nelson SJ, Vigneron D. Magnetic Resonance Molecular Imaging of Prostate Cancer. JMRI 2002;16(4).

Swanson MG, Vigneron DB, Tabatabai ZL, Males RG, Schmitt L, Carroll PR, James JK, Hurd RE, Kurhanewicz J. Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted post-surgical prostate tissues. Magn Reson Med 2003; 50: 944-954.

Coakley FV, Qayyum A, and Kuranewicz J. Magnetic resonance imaging and spectroscopic imaging of prostate cancer. Journal of Urology 2003;170: S69-76.

Pickett B, TenHaken RK, Kurhanewicz J, et al. Time to metabolic atrophy after permanent prostate seed implantation based on magnetic resonance spectroscopic imaging. Int J Radiat Oncol Biol Phys 2004;59:665-673.

Pouliot J, Kim Y, Lessard E, Hsu IC, Vigneron DB, Kurhanewicz J. Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging. Int J Radiat Oncol Biol Phys 2004;59:1196-1207.

Qayyum A, Coakley FV, Lu Y, Olpin JD, Wu L, Yeh BM, Carroll PR, Kurhanewicz J. Organ-Confined Prostate Cancer: Effect of Prior Transrectal Biopsy on Endorectal MRI and MR Spectroscopic Imaging. AJR Am J Roentgenol 2004;183:1079-1083.

Coakley FV, Teh HS, Qayyum A, Swanson MG, Lu Y, Roach M, Pickett B, Shinohara K, Vigneron DB, Kurhanewicz J. Endorectal MR Imaging and MR Spectroscopic Imaging for Locally Recurrent Prostate Cancer after External Beam Radiation Therapy. Preliminary Experience. Radiology 2004;233:441-448.

Pickett B, Kurhanewicz J, Coakley F, Shinohara K, Fein B, Roach M. Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2004;60:1047-1055.

Jung JA, Coakley FV, Vigneron DB, Swanson MG, Qayyum A, Weinberg V, Jones KD, Carroll PR, Kurhanewicz J. Prostate Depiction at Endorectal MR Spectroscopic Imaging: Investigation of a Standardized Evaluation System. Radiology 2004;233:701-708.

Pucar D, Koutcher JA, Shah A, Dyke JP, Schwartz L, Thaler H, Kurhanewicz J, Scardino PT, Kelly WK, Hricak H, Zakian KL. Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse. Clin Prostate Cancer 2004;3:174-181.

Noworolski SM, Henry RG, Vigneron DB, Kurhanewicz J. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI. Magn Reson Med 2005;53:249-255.

Cunningham CH, Vigneron DB, Marjanska M, Chen AP, Xu D, Hurd RE, Kurhanewicz J, Garwood M, Pauly JM. Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3 T. Magn Reson Med 2005; 53:1033-1039.

Prando A, Kurhanewicz J, Borges AP, Oliveira EM, Jr., Figueiredo E. Prostatic Biopsy Directed with Endorectal MR Spectroscopic Imaging Findings in Patients with Elevated Prostate Specific Antigen Levels and Prior Negative Biopsy Findings: Early Experience. Radiology 2005; 236:903-910.

Kim Y, Noworolski SM, Pouliot J, Hsu IC Vigneron, D.B., and Kurhanewicz J. Expandable and Rigid Endorectal Coils for Prostate Magnetic Resonance Imaging and Spectroscopic Imaging: Impact on Prostate Distortion and Image Registration. Medical Physics 2005; 32(12):3569-3578.

Seo Y, Kurhanewicz J, Franc BL, Hawkins RA, Hasegawa BH. Improved prostate cancer imaging with SPECT/CT and MRI/MRSI. Ieee Transactions on Nuclear Science 2005; 52:1316-1320.

Hom JJ, Coakley FV, Simko JP, Qayyum A, Lu Y, Schmitt L, Carroll PR, Kurhanewicz J. Prostate cancer: Endorectal MR imaging and MR spectroscopic imaging - Distinction of true-positive results from chance-detected lesions. Radiology 2006; 238: 192-199.

Alterovitz R, Goldberg K, Pouliot J, Hsu IC, Kim Y, Noworolski SM, Kurhanewicz J. Registration of MR prostate images with biomechanical modeling and nonlinear parameter estimation. Med Phys 2006; 33:446-454.

Pels P, Ozturk-Isik E, Swanson MG, Vanhamme L, Kurhanewicz J, Nelson SJ, Huffel SV. Quantification of prostate MRSI data by model-based time domain fitting and frequency domain analysis. NMR Biomed 2006; 19:188-197.

Pickett B, Kurhanewicz J, Pouliot J, Weinberg V, Shinohara K, Coakley F, Roach M, 3rd. Three-dimensional conformal external beam radiotherapy compared with permanent prostate implantation in low-risk prostate cancer based on endorectal magnetic resonance spectroscopy imaging and prostate-specific antigen level. Int J Radiat Oncol Biol Phys 2006.

Swanson MS, Zektzer AS, Tabatabai ZL, Simko JP, Jarso S, Keshari KR, Schmitt L, Carroll PR, Shinohara K, Vigneron DB, Kurhanewicz, J. Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy. Magn Reson Med 2006;55:1257-1264.

1/30/07